Clinical trial
Identification of Microplastics in Liver, Stomach, Blood, and Feces of Obese Patients and Their Association Analysis with Macrogenomics and Metabolomics.
Active, not recruiting · Not applicable · 1 countries · Registry ID NCT06826586
What this study is about
The aim of this study was to identify and quantify microplastics in the stomach, liver, feces, and blood of obese patients to be treated with bariatric surgery by using a variety of advanced analytical techniques to explore the association between obesity and visceral microplastics, and to investigate the effects of microplastics on the visceral microbiota and metabolic profiles of obese patients by combining the macro-genomic and metabolomics approaches.
Basic eligibility
Full registry criteria
Treatments and study arms
Measuring the microplastics
Measuring the type, nature, and abundance of microplastics in stomach, liver, feces, and blood
Primary outcomes
Differences in different microbial communities in the stomach, liver, feces, and blood of obese patients
Study locations
1 locations were listed when this page was built. The first 40 are shown.